Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the Indonesian healthcare setting
2017 ◽
Vol 34
(1)
◽
pp. 55-63
◽
2013 ◽
Vol 34
(1)
◽
pp. 9-17
◽